Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

被引：0
作者：
M. Schmidt-Hieber
J. Bierwirth
D. Buchheidt
O. A. Cornely
M. Hentrich
G. Maschmeyer
E. Schalk
J. J. Vehreschild
Maria J. G. T. Vehreschild
机构：
[1] HELIOS Klinikum Berlin-Buch,Clinic for Hematology, Oncology, Tumor Immunology and Palliative Care
[2] BZH GmbH,Deutsches Beratungszentrum für Hygiene
[3] University of Heidelberg,3rd Department of Internal Medicine
[4] University of Cologne, Hematology and Oncology
[5] German Center for Infection Research (DZIF), Mannheim University Hospital
[6] partner site Bonn-Cologne,1st Department of Internal Medicine
[7] University of Cologne,Clinical Trials Centre Cologne, ZKS Köln
[8] Rotkreuzklinikum München,Department III for Internal Medicine, Hematology and Oncology
[9] Ernst-von-Bergmann Klinikum,Department of Hematology, Oncology and Palliative Care
[10] Otto-von-Guericke University,Department of Hematology and Oncology, Medical Center
[11] Hospital of the University of Cologne,1st Department of Internal Medicine
来源：
Annals of Hematology | 2018年 / 97卷
关键词：
Abdominal complications; Colitis; Diarrhea; Chemotherapy; Cancer; Infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer patients frequently suffer from gastrointestinal complications. In this manuscript, we update our 2013 guideline on the diagnosis and management of gastrointestinal complications in adult cancer patients by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). An expert group was put together by the AGIHO to update the existing guideline. For each sub-topic, a literature search was performed in PubMed, Medline, and Cochrane databases, and strengths of recommendation and the quality of the published evidence for major therapeutic strategies were categorized using the 2015 European Society for Clinical Microbiology and Infectious Diseases (ESCMID) criteria. Final recommendations were approved by the AGIHO plenary conference. Recommendations were made with respect to non-infectious and infectious gastrointestinal complications. Strengths of recommendation and levels of evidence are presented. A multidisciplinary approach to the diagnosis and management of gastrointestinal complications in cancer patients is mandatory. Evidence-based recommendations are provided in this updated guideline.
引用
收藏
页码：31 / 49
页数：18
相关论文
共 1022 条
[81]  
Delaunoit T(1996)High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission Support Care Cancer 4 294-1042
[82]  
Goldberg RM(2001)NCCN: fever and neutropenia Cancer Control 8 16-801
[83]  
Sargent DJ(2014)Multistate point-prevalence survey of health care-associated infections N Engl J Med 370 1198-1163
[84]  
Morton RF(2002)Clostridium difficile infection in patients with neutropenia Clin Infect Dis 34 723-14
[85]  
Fuchs CS(1999)Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation Bone Marrow Transplant 23 1039-419
[86]  
Findlay BP(2003)Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation Bone Marrow Transplant 31 795-1940
[87]  
Kuebler JP(1985)Clostridium difficile colitis in leukemia patients Eur J Cancer Clin Oncol 21 1159-455
[88]  
Colangelo L(2009)Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia Ann Hematol 89 9-1580
[89]  
O'Connell MJ(2007)Autocatalytic cleavage of Clostridium difficile toxin B Nature 446 415-1084
[90]  
Smith RE(2008)Clostridium difficile—more difficult than ever N Engl J Med 359 1932-133
45678910111213